Stress ulcer prophylaxis in mechanically ventilated patients

Area of Science:

• Critical Care Medicine
• Gastroenterology
• Pharmacology

Background:

• Mechanical ventilation increases the risk of upper gastrointestinal bleeding (UGIB).
• Prophylaxis with acid-suppressing agents like proton pump inhibitors (PPIs) and histamine 2 receptor antagonists (H2RAs) is common in these patients.
• Comparative effectiveness data for PPIs versus H2RAs or placebo for UGIB prophylaxis in mechanically ventilated patients require synthesis.

Purpose of the Study:

• To compare the efficacy and safety of PPIs versus H2RAs or placebo for UGIB prophylaxis in mechanically ventilated patients.
• To evaluate the impact of PPIs on clinically important UGIB, overall UGIB, mortality, ventilator-associated pneumonia (VAP), and Clostridium difficile infection (CDI).

Main Methods:

• A meta-analysis of randomized controlled trials (RCTs) was conducted.
• Data from eight RCTs involving 32,873 patients were pooled.
• Pooled risk ratios (RR) with 95% confidence intervals (CI) were calculated for all outcomes.

Main Results:

• Proton pump inhibitors significantly reduced the risk of clinically important UGIB (RR: 0.53; 95% CI: 0.32, 0.89).
• PPIs also significantly lowered the risk of overall UGIB compared to H2RAs and placebo.
• No significant differences were observed in mortality, VAP, or CDI rates between the groups.

Conclusions:

• Proton pump inhibitors demonstrate superiority over H2 receptor antagonists and placebo for preventing UGIB in mechanically ventilated patients.
• The use of PPIs for UGIB prophylaxis in this population does not appear to increase the risk of mortality, VAP, or CDI.
• These findings support the use of PPIs for UGIB prophylaxis in critically ill, mechanically ventilated patients.